• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchCytoMed Therapeutics
    Picture of CytoMed Therapeutics logo

    GDTC — CytoMed Therapeutics Share News

    $0.920.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMicro CapSucker Stock
    • Market Cap
      $10.97m
    • Enterprise Value
      $10.52m
    • Revenue
      SG$0.32m
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • GDTC Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    GDTC Dividends
    • Brief: Cytomed Therapeutics Limited Announces Pricing Of Initial Public Offering

      14/04/2023 01:01
    • Brief: CytoMed Therapeutics Sees U.S. IPO Of Up To 2.4 Mln Shares - SEC Filing

      01/02/2023 12:12
    • Brief: Good Technology files to withdraw IPO plans

      30/10/2015 14:04
    • Refile: BRIEF-BlackBerry to acquire Good Technology

      04/09/2015 14:05
    • BlackBerry to buy competitor Good Technology for $425 mln (updated)

      04/09/2015 13:52
    • Brief: Good Technology and VMware resolve patent litigation

      15/04/2015 13:03
    Previous12Next

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.